Wealth Enhancement Advisory Services’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-17,497
Closed -$1.31M 223
2018
Q3
$1.31M Buy
+17,497
New +$1.55M 0.08% 93
2017
Q1
Sell
-13,673
Closed -$1.58M 197
2016
Q4
$1.58M Buy
13,673
+7,769
+132% +$865K 0.19% 63
2016
Q3
$622K Buy
+5,904
New +$639K 0.09% 129
2016
Q2
Sell
-9,881
Closed -$998K 129
2016
Q1
$998K Buy
9,881
+1,578
+19% +$162K 0.2% 108
2015
Q4
$994K Buy
+8,303
New +$961K 0.25% 75

Other funds holding CELG

Wealth Enhancement Advisory Services's CELG Position: Q4 2018 in Review

Wealth Enhancement Advisory Services sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 17,497 shares — an estimated $1.31M sold.

Wealth Enhancement Advisory Services first reported a position in CELG in Q4 2015 and held it in 5 quarters. The position peaked at $1.58M in Q4 2016. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Wealth Enhancement Advisory Services reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 17,497 Celgene Corp shares in Q4 2018, an estimated $1.31M.
  • Wealth Enhancement Advisory Services first reported a position in Celgene Corp in Q4 2015 and held it in 5 quarters.
  • Wealth Enhancement Advisory Services's Celgene Corp position peaked at $1.58M in Q4 2016.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Wealth Enhancement Advisory Services's 13F filing for Q4 2018, filed 4 Feb 2019.